Further, it caused an increase in the activation of the Akt/GSK-3 pathway, indicating that IGF-1 could be a potential therapy for diabetic cardiomyocytes [9]
Exenatide Extended-Release: An Updated Review of Its Use in Type 2 Diabetes Mellitus
While GLP-1 drugs like Ozempic are not yet approved for Alzheimers prevention, patients who may benefit from early discussions with a neurologist include: Adults over 50 with prediabetes or type 2 diabetes Individuals with a family history of Alzheimers or dementia Patients with obesity, insulin resistance , or metabolic syndrome Those experiencing mild cognitive impairment (MCI) or early memory concerns Our neurologists can provide personalized brain health evaluations , collaborate with primary care or endocrinology specialists, and help guide decisions around GLP-1 use and Alzheimers risk reduction
We'll set aside compounding for a minute, but let's assume we're getting the actual drug and just getting it because I know I'm heavy and I know that I've exercised and it doesn't really work, and maybe I just want to take it for 6 months and shed the 10 pounds
Kim BJ, Sung KC, Kim BS, Kang JH, Lee KB, Kim H, Lee MH
Some arent even waiting for approval from the Food and Drug Administration, instead racing to acquire it through sketchy means